32 results
8-K
EX-99.2
RLAY
Relay Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
are excited to disclose at least one new innovative program from our Dynamo platform later this year.”
“Our assessment of RLY-2608’s evolving clinical profile … to advance RLY-2608 towards registrational trial(s), to advance its preclinical pipeline of innovative programs, and for working capital and other
8-K
EX-99.1
c0590dn
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
EX-99.1
bs7 5fj2wpun9t7sk
5 May 22
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
12:00am
PRE 14A
sex2qh8gm950o567v2i
1 Apr 22
Preliminary proxy
4:30pm
8-K
EX-99.2
uqrlnxo6n77m b9
8 Oct 21
Regulation FD Disclosure
6:07am